Trxade Deferred Long Term Liab vs Net Invested Capital Analysis
| MEDS Stock | USD 6.01 0.03 0.50% |
Trxade financial indicator trend analysis is much more than just breaking down Trxade Group prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Trxade Group is a good investment. Please check the relationship between Trxade Deferred Long Term Liab and its Net Invested Capital accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Trxade Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Deferred Long Term Liab vs Net Invested Capital
Deferred Long Term Liab vs Net Invested Capital Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Trxade Group Deferred Long Term Liab account and Net Invested Capital. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Trxade's Deferred Long Term Liab and Net Invested Capital is -0.41. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Net Invested Capital in the same time period over historical financial statements of Trxade Group, assuming nothing else is changed. The correlation between historical values of Trxade's Deferred Long Term Liab and Net Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Trxade Group are associated (or correlated) with its Net Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Invested Capital has no effect on the direction of Deferred Long Term Liab i.e., Trxade's Deferred Long Term Liab and Net Invested Capital go up and down completely randomly.
Correlation Coefficient | -0.41 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Net Invested Capital
The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.Most indicators from Trxade's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Trxade Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Trxade Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Selling General Administrative is likely to drop to about 4.8 M in 2024. Discontinued Operations is likely to drop to about (1.5 M) in 2024
| 2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 9.9M | 11.4M | 8.3M | 6.6M | Depreciation And Amortization | 138.9K | 216.8K | 1.0M | 1.1M |
Trxade fundamental ratios Correlations
Click cells to compare fundamentals
Trxade Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Trxade fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 5.6M | 9.8M | 5.8M | 3.7M | 12.5M | 13.2M | |
| Other Current Liab | 98.9K | 219.3K | 270.4K | 1.0M | 2.0M | 1.2M | |
| Total Current Liabilities | 520.8K | 842.2K | 926.0K | 2.1M | 11.6M | 12.1M | |
| Total Stockholder Equity | 4.1M | 8.7M | 3.8M | 763.1K | 542.4K | 569.5K | |
| Net Debt | (1.9M) | (5.3M) | (1.9M) | 450.3K | 7.0M | 7.3M | |
| Retained Earnings | (8.4M) | (10.9M) | (16.2M) | (19.7M) | (33.2M) | (31.6M) | |
| Accounts Payable | 334.6K | 256.8K | 477.0K | 729.2K | 2.1M | 2.2M | |
| Cash | 2.9M | 5.9M | 3.1M | 1.1M | 151.9K | 144.3K | |
| Cash And Short Term Investments | 2.9M | 5.9M | 3.1M | 1.1M | 151.9K | 144.3K | |
| Common Stock Shares Outstanding | 395.3K | 513.7K | 542.5K | 564.9K | 2.4M | 2.5M | |
| Liabilities And Stockholders Equity | 5.6M | 9.8M | 5.8M | 3.7M | 12.5M | 13.2M | |
| Non Current Liabilities Total | 910.5K | 271.3K | 1.1M | 1.2M | 434.2K | 412.5K | |
| Other Stockholder Equity | 12.5M | 19.6M | 20.0M | 20.5M | 33.8M | 35.5M | |
| Total Liab | 1.4M | 1.1M | 2.0M | 3.4M | 12.0M | 12.6M | |
| Total Current Assets | 3.8M | 9.2M | 4.4M | 2.1M | 2.8M | 2.1M | |
| Common Stock | 65.0 | 81.0 | 82.0 | 99.0 | 9.0 | 8.55 | |
| Short Long Term Debt Total | 997.8K | 627.5K | 1.2M | 1.6M | 7.1M | 7.5M | |
| Short Term Debt | 87.4K | 356.2K | 178.6K | 363.5K | 6.7M | 7.0M | |
| Property Plant And Equipment Net | 932.7K | 549.8K | 1.3M | 1.1M | 806.6K | 582.6K | |
| Non Current Assets Total | 1.8M | 571.4K | 1.4M | 1.6M | 9.8M | 10.3M | |
| Non Currrent Assets Other | 109.9K | 21.6K | 60.1K | 49.0K | 10.5K | 10.0K | |
| Net Receivables | 792.1K | 1.9M | 979.0K | 729.0K | 2.5M | 2.6M | |
| Inventory | 56.8K | 1.3M | 56.3K | 119.6K | 968.0 | 919.6 | |
| Other Current Assets | 82.5K | 151.2K | 216.4K | 110.9K | 478.4K | 502.3K | |
| Property Plant And Equipment Gross | 932.7K | 549.8K | 1.3M | 1.1M | 806.6K | 655.2K | |
| Capital Surpluse | 7.8M | 9.0M | 12.5M | 19.6M | 22.6M | 23.7M | |
| Property Plant Equipment | 932.7K | 549.8K | 1.3M | 1.1M | 1.3M | 724.2K | |
| Net Tangible Assets | 3.4M | 8.7M | 3.8M | 312.3K | 359.1K | 341.2K | |
| Other Assets | 109.9K | 409.0K | 60.1K | 49.0K | 44.1K | 41.9K | |
| Long Term Debt | 404.1K | 522.6K | 225K | 333.3K | 25K | 23.8K | |
| Short Long Term Debt | 262.3K | 321.5K | 225K | 166.7K | 6.5M | 6.9M | |
| Net Invested Capital | 4.4M | 8.9M | 3.8M | 1.3M | 7.1M | 4.3M | |
| Net Working Capital | 3.3M | 8.4M | 3.4M | (53.7K) | (8.8M) | (8.4M) | |
| Capital Stock | 65.0 | 81.0 | 82.0 | 99.0 | 9.0 | 8.55 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Trxade Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Trxade Group information on this page should be used as a complementary analysis to other Trxade's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Trxade Stock analysis
When running Trxade's price analysis, check to measure Trxade's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trxade is operating at the current time. Most of Trxade's value examination focuses on studying past and present price action to predict the probability of Trxade's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trxade's price. Additionally, you may evaluate how the addition of Trxade to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Trxade's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trxade. If investors know Trxade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trxade listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.766 | Earnings Share (17.96) | Revenue Per Share 10.827 | Quarterly Revenue Growth 0.043 | Return On Assets (0.56) |
The market value of Trxade Group is measured differently than its book value, which is the value of Trxade that is recorded on the company's balance sheet. Investors also form their own opinion of Trxade's value that differs from its market value or its book value, called intrinsic value, which is Trxade's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trxade's market value can be influenced by many factors that don't directly affect Trxade's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trxade's value and its price as these two are different measures arrived at by different means. Investors typically determine if Trxade is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trxade's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.